Jasper Therapeutics, Inc. (JSPR) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 35.08M |
| Enterprise Value | 7.62M |
| P/E Ratio | -0.43 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 14.04 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0.13 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -2.69 |
| Return On Equity | -6.19 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -1.06M |
| EBITDA | -74.75M |
| Net Income | -75.8M |
| Diluted EPS | -3.95 |
Balance Sheet
| Total Cash | 7.31M |
| Total Cash/Share | 0.25 |
| Total Debt | 270,000 |
| Total Debt/Equity | 0.19 |
| Current Ratio | 1.47 |
| Book Value Per Share | 0.05 |
Price History
| 52-Week Change | -76.57 |
| 52-Week High | 3.05 |
| 52-Week Low | 0.32 |
| Moving Average 50 Days | 0.62 |
| Moving Average 200 Days | 1.14 |
Statistics
| Average Volume | 1.54M |
| Shares Outstanding | 16.25M |
| % Held by Institutions | 82.5 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | January 04, 2024 |
AD
